American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 3 , Pages 188-194 , May 2008

Ménière disease: diagnostic instrumental support

  • Enrico Muzzi, MD
    • ,
  • Alessandra Rinaldo, MD, FACS
    • ,
  • Alfio Ferlito, MD, DLO, DPath, FRCS, FRCSEd, FRCSGlasg, FRCSI, FACS, FHKCORL, FDSRCS, FRCPath, FASCP, MCAP

      Affiliations

    • Corresponding Author InformationCorresponding author. University of Udine, Policlinico Universitario, Piazzale S. Maria della Misericordia, I-33100 Udine, Italy. Tel.: +39 0432 559302; fax: +39 0432 559339.

Received 2 March 2007

References 

  1. Thorp MA, James AL. Prosper Ménière. Lancet. 2005;366:2137–2139
  2. Merchant SN, Adams JC, Nadol JB. Pathophysiology of Ménière's syndrome: are symptoms caused by endolymphatic hydrops?. Otol Neurotol. 2005;26:74–81
  3. Alpay HC, Linthicum FH. Endolymphatic hydrops without Ménière's syndrome. Otol Neurotol. 2007;28:31–36
  4. Committee on Hearing and Equilibrium . Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. 1995;113:181–185
  5. Kim HH, Wiet RJ, Battista RA. Trends in the diagnosis and the management of Ménière's disease: results of a survey. Otolaryngol Head Neck Surg. 2005;132:722–726
  6. Chung WH, Cho DY, Choi JY, et al. Clinical usefulness of extratympanic electrocochleography in the diagnosis of Ménière's disease. Otol Neurotol. 2004;25:144–149
  7. Lin MY, Timmer FC, Oriel BS, et al. Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic saccular hydrops. Laryngoscope. 2006;116:987–992
  8. Savastano M, Guerrieri V, Marioni G. Evolution of audiometric pattern in Ménière's disease: long-term survey of 380 cases evaluated according to the 1995 guidelines of the American Academy of Otolaryngology—Head and Neck Surgery. J Otolaryngol. 2006;35:26–29
  9. Mateijsen DJM, Van Hengel PWJ, Van Huffelen WM, et al. Pure-tone and speech audiometry in patients with Ménière's disease. Clin Otolaryngol Allied Sci. 2001;26:379–387
  10. Muchnik C, Hildesheimer M, Rubinstein M, et al. Low frequency air-bone gap in Ménière's disease without middle ear pathology. A preliminary report. Am J Otol. 1989;10:1–4
  11. de Sousa LC, Piza MR, da Costa SS. Diagnosis of Ménière's disease: routine and extended tests. Otolaryngol Clin North Am. 2002;35:547–564
  12. Cueva RA. Auditory brainstem response versus magnetic resonance imaging for the evaluation of asymmetric sensorineural hearing loss. Laryngoscope. 2004;114:1686–1692
  13. Friedrichs I, Thornton AR. Endolymphatic hydrops in asymptomatic ears in unilateral Ménière's disease. Laryngoscope. 2001;111:857–860
  14. Munro KJ, Smith R, Thornton AR. Difficulties experienced in implementing the ABR travelling wave velocity (Delta V) technique with two commercially available systems. Br J Audiol. 1995;29:23–29
  15. Mrowinski D, Gerull G, Nubel K, et al. Masking and pitch shift of tone bursts and clicks by low-frequency tones. Hear Res. 1995;85:95–102
  16. Mrowinski D, Scholz G, Krompass S, et al. Diagnosis of endolymphatic hydrops by low-frequency masking. Audiol Neurootol. 1996;1:125–134
  17. Don M, Kwong B, Tanaka C. A diagnostic test for Ménière's disease and cochlear hydrops: impaired high-pass noise masking of auditory brainstem responses. Otol Neurotol. 2005;26:711–722
  18. De Valck CFJ, Claes GME, Wuyts FL, Van de Heyning PH. Lack of diagnostic value of high-pass noise masking auditory brainstem responses in Ménière’s disease. Otol Neurotol. 2007;28:700–707
  19. Anft D, Jamali Y, Scholz G, Mrowinski D. Electrocochleography and phase audiometry in diagnosis of Ménière disease. HNO. 2001;49:102–108[In German]
  20. Hall M, Hughes R. Maximum compliance and the symptom of fullness in Ménière disease. Arch Otolaryngol. 1975;101:227–231
  21. Herman LE, Carver WF, Arenberg IK. Static compliance of the eardrum in Ménière disease. Arch Otolaryngol. 1977;103:84–86
  22. Franco-Vidal V, Legarlantezec C, Blanchet H, et al. Multifrequency admittancemetry in Ménière's disease: a preliminary study for a new diagnostic test. Otol Neurotol. 2005;26:723–727
  23. Chen CN, Young YH. Differentiating the cause of acute sensorineural hearing loss between Ménière's disease and sudden deafness. Acta Otolaryngol. 2006;126:25–31
  24. Kubo T, Sakashita T, Kusuki M, et al. Frequency analysis of evoked otoacoustic emissions in Ménière's disease. Acta Otolaryngol Suppl. 1995;519:275–281
  25. Haginomori SI, Makimoto K, Tanaka H, et al. Spontaneous otoacoustic emissions in humans with endolymphatic hydrops. Laryngoscope. 2001;111:96–101
  26. Fetterman BL. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops. Laryngoscope. 2001;111:946–954
  27. Ferraro JA, Durrant JD. Electrocochleography in the evaluation of patients with Ménière's disease/endolymphatic hydrops. J Am Acad Audiol. 2006;17:45–68
  28. Kim HH, Kumar A, Battista RA, et al. Electrocochleography in patients with Ménière's disease. Am J Otolaryngol. 2005;26:128–131
  29. Conlon BJ, Gibson WP. Electrocochleography in the diagnosis of Ménière's disease. Acta Otolaryngol. 2000;120:480–483
  30. Devaiah AK, Dawson KL, Ferraro JA, et al. Utility of area curve ratio electrocochleography in early Ménière disease. Arch Otolaryngol Head Neck Surg. 2003;129:547–551
  31. Ikino CM, de Almeida ER. Summating potential–action potential waveform amplitude and width in the diagnosis of Ménière's disease. Laryngoscope. 2006;116:1766–1769
  32. Meissner R. Behavior of the nystagmus in Ménière's attack. Arch Otorhinolaryngol. 1981;233:173–177
  33. Mateijsen DJM, Hengel PWJ, Kingma H, et al. Vertigo and electronystagmography in uni- and bilateral Ménière's disease. ORL J Otorhinolaryngol Relat Spec. 2001;63:341–348
  34. Wu Z, Zhang S, Zhou N, et al. Significance of some otologic function tests in diagnosis of Ménière's disease. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2006;20:433–435[in Chinese]
  35. Huygen PL, Nicolasen MG, Verhagen WI, Theunissen EJ. Contralateral hyperactive caloric response in unilateral labyrinthine weakness. Acta Otolaryngol. 1989;107:1–4
  36. Rauch SD. Vestibular evoked myogenic potentials. Curr Opin Otolaryngol Head Neck Surg. 2006;14:299–304
  37. Kuo SW, Yang TH, Young YH. Changes in vestibular evoked myogenic potentials after Ménière attacks. Ann Otol Rhinol Laryngol. 2005;114:717–721
  38. Welgampola MS, Colebatch JG. Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology. 2005;64:1682–1688
  39. Rauch SD, Silveira MB, Zhou G, et al. Vestibular evoked myogenic potentials versus vestibular test battery in patients with Ménière's disease. Otol Neurotol. 2004;25:981–986
  40. Klockhoff I, Lindblom U. Endolymphatic hydrops revealed by glycerol test. Preliminary report. Acta Otolaryngol. 1966;61:459–462
  41. Inoue Y, Kanzaki J, O-Uchi T, et al. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss. Auris Nasus Larynx. 1997;24:143–149
  42. Kimura H, Aso S, Watanabe Y. Prediction of progression from atypical to definite Ménière's disease using electrocochleography and glycerol and furosemide tests. Acta Otolaryngol. 2003;123:388–395
  43. Wang S, Chen T. Application of electronystagmography glycerine test for diagnosing Ménière's disease. Zhonghua Er Bi Yan Hou Ke Za Zhi. 1997;32:84–87[in Chinese]
  44. Shojaku H, Takemori S, Kobayashi K, et al. Clinical usefulness of glycerol vestibular-evoked myogenic potentials: preliminary report. Acta Otolaryngol Suppl. 2001;545:65–68
  45. Ohki M, Matsuzaki M, Sugasawa K, et al. Vestibular evoked myogenic potentials in ipsilateral delayed endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec. 2002;64:424–428
  46. Seo T, Node M, Yukimasa A, et al. Furosemide loading vestibular evoked myogenic potential for unilateral Ménière's disease. Otol Neurotol. 2003;24:283–288
  47. Canale A, Lacilla M, Giordano C, et al. The prognostic value of otoacoustic emission test in low frequency sudden hearing loss. Eur Arch Otorhinolaryngol. 2005;262:208–212
  48. Nakagawa H, Watanabe Y, Mizukoshi K, et al. Plain radiological findings in Ménière's disease. Auris Nasus Larynx. 1994;21:137–142
  49. Krombach GA, van den Boom M, Di Martino E, et al. Computed tomography of the inner ear: size of anatomical structures in the normal temporal bone and in the temporal bone of patients with Ménière's disease. Eur Radiol. 2005;15:1505–1513
  50. Xenellis J, Vlahos L, Papadopoulos A, et al. Role of the new imaging modalities in the investigation of Ménière's disease. Otolaryngol Head Neck Surg. 2000;123:114–119
  51. Koesling S, Rasinski C, Amaya B. Imaging and clinical findings in large endolymphatic duct and sac syndrome. Eur J Radiol. 2006;57:54–62
  52. Schmalbrock P, Dailiana T, Chakeres DW, et al. Submillimeter-resolution MR of the endolymphatic sac in healthy subjects and patients with Ménière disease. AJNR Am J Neuroradiol. 1996;17:1707–1716
  53. Kobayashi M, Tsunoda A, Akita K, et al. Estimation of the endolymphatic sac and vestibular aqueduct using magnetic resonance imaging. Laryngoscope. 2003;113:1015–1021
  54. Valk WL, Wit HP, Segenhout JM, et al. Morphology of the endolymphatic sac in the guinea pig after an acute endolymphatic hydrops. Hear Res. 2005;202:180–187
  55. Sugiura M, Naganawa S, Nakashima T, et al. Magnetic resonance imaging of endolymphatic sac in acute low-tone sensorineural hearing loss without vertigo. ORL J Otorhinolaryngol Relat Spec. 2003;65:254–260
  56. Tanioka H, Kaga H, Zusho H, et al. MR of the endolymphatic duct and sac: findings in Ménière disease. AJNR Am J Neuroradiol. 1997;18:45–51
  57. Zou J, Pyykko I, Bretlau P, et al. In vivo visualization of endolymphatic hydrops in guinea pigs: magnetic resonance imaging evaluation at 4.7 tesla. Ann Otol Rhinol Laryngol. 2003;112:1059–1065
  58. Niyazov DM, Andrews JC, Strelioff D, et al. Diagnosis of endolymphatic hydrops in vivo with magnetic resonance imaging. Otol Neurotol. 2001;22:813–817
  59. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Ménière's disease. Laryngoscope. 2007;117:415–420
  60. Carfrae MJ, Holtzman A, Eames F, Parnes SM, Lupinetti A. 3 Tesla delayed contrast magnetic resonance imaging evaluation of Ménière's disease. Laryngoscope. 2008;118:501–505
  61. Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T. Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence; 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Euro Radiol. 2008;in press

PII: S0196-0709(07)00062-2

doi: 10.1016/j.amjoto.2007.04.011

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 3 , Pages 188-194 , May 2008

Article Tools